Digipharm brings together industry expertise, a mature concept and revolutionary blockchain technology to facilitate the transformation of healthcare to a value-based approach.
Another Crypto currency is coming to the crypto space. If you are a Crypto Currency investor or enthusiast you will not probably miss this incoming project that concerns about the most important thing in the world and belongs to their mission and vision which is the people’s HEALTH. Digipharms’ solutions aim to accelerate the much needed restructuring of healthcare delivery systems to a value-based approach. The inherent flaws of current global healthcare infrastructure result in substantial inefficiency, wastage and sub-optimal health outcomes for the most important stakeholder; the PATIENT. Currently there is a lack of incentive for health systems and providers to focus on mutually beneficial collaboration and the maximization of patient outcomes. Using the most power technology on this era it aims to utilize innovative blockchain technology to overcome barriers to patient access and innovative pricing, reduce costs for all stakeholders, and bypass infrastructural limitations to drive value improvement, incentivise innovation and expedite the transformation to personalized healthcare.
VISION
Digipharms’ vision is to be ‘the pioneer of value-based healthcare delivery, innovative evidence generation and patient empowerment across the healthcare industry’ using revolutionary blockchain technology.
GOALS
To remove infrastructural barriers and automate the implementation of innovative value-based pricing agreements on a fully independent platform; in order to facilitate personalised reimbursement of health technology on a ‘fee for performance’ basis for the mutual benefit of patients, payers and manufacturers.
To develop the world’s first ‘live’ RWE platform. Allowing the utilisation of real world data (RWD) as soon as it becomes available, to inform health related research, decision making and to incentivise patients to contribute their data.
Digipharm tokens
DPH tokens will belong to the list of among the best Utility tokens.
To develop the world’s first ‘live’ RWE platform. Allowing the utilisation of real world data (RWD) as soon as it becomes available, to inform health related research, decision making and to incentivise patients to contribute their data.
Digipharm tokens
DPH tokens will belong to the list of among the best Utility tokens.
What is a Utility Token?
Utility tokens, also called user tokens or app coins, represent future access to a company’s product or service. The defining characteristic of utility tokens is that they are not designed as investments; if properly structured, this feature exempts utility tokens them from federal laws governing securities. Credits to:
DPH token will be used to pay license/access fees on Digipharm platforms. Access fees will invariably be determined and stipulated in USD value and the quantity of tokens required will depend on the type of access (manufacturer, patient, payer or provider) combined with the form of interaction required. The quantity of tokens required for such interactions is subject to change, relative to the market value of DPH.
DPH token characteristics
» DPH Supply: 100,000,000 Fixed (ERC-20)
» Ticker code: DPH
» Decimal Places: 18
» Token Price 1.00 USD
TOKEN INFORMATIONS, FUNDING USAGE AND TOKEN DISTRIBUTION:
)
(
)
Commitment to charitable causes:
0.5% of ICO proceeds will be allocated to the Digipharm charitable foundation (to be established) with the goal to develop sustainable health related services in third world countries. Digipharm will further commit 2.5% of net profits per annum towards the charitable foundation. If the foundation cannot be established due to regulatory or legal reasons, Digipharm intends to allocated the above mentioned funds to a third party foundation with similar goals.
0.5% of ICO proceeds will be allocated to the Digipharm charitable foundation (to be established) with the goal to develop sustainable health related services in third world countries. Digipharm will further commit 2.5% of net profits per annum towards the charitable foundation. If the foundation cannot be established due to regulatory or legal reasons, Digipharm intends to allocated the above mentioned funds to a third party foundation with similar goals.
No comments:
Post a Comment